Alexander Kamb
Senior Vice President, Discovery Research @ Amgen
San Francisco Bay Area, United States
Alexander Kamb is a startup investor at Amgen in San Francisco Bay Area. Alexander Kamb is senior vice president, Discovery Research. In 2006, Kamb joined Amgen to direct Oncology Research at their South San Francisco site. He took over the leadership of the Neuroscience Therapeutic Area and was promoted to vice president, Research, and was given the remit to build a specialized department within Amgen Research (GenomeAnalysis Unit) focused on cross-disease-area applications of next-generation sequencing.Prior to joining Amgen, Kamb worked in the biotechnology field specializing in the genetics of cancer, then in the Pharmaceutical sector where he led the Novartis Oncology Research Group.Kamb received his A.B. from Harvard University and his Ph.D. from Caltech after a postdoctoral fellowship at UCSF.
Last updated:
For AI agents: llms.txt
About Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases. The company is values-based and deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious diseases. They offer products for treating illness in the areas ofoncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.
Amgen Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Vance Coffman
Board of Director
|
|||
|
Alexander Kamb
Senior Vice President, Discovery Research
|
|||
David Haddad
Director of Product Management
|
|||
Elliott Sigal
Co-Chair, Scientific Advisory Board
|
|||
Esteban Santos
Executive Vice President, Operations
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
